phenylalanine has been researched along with Graft-Versus-Host Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Baillif, S; Elmaleh, V; Ferrete, T; Loschi, M; Martel, A; Rocher, F; Tieulie, N | 2 |
| Schubert-Tennigkeit, AA | 1 |
| Chhabra, S; Conto, JE; Hamadani, M; Hari, PN; Jerkins, JH; Shah, NN; Zellner, K | 1 |
| Armutlulu, A; Balaram, H; Balasubramanian, S; Bartosh, TJ; Broda, M; Brown, LE; Burroughs, LM; Burrows, F; Cardoso, JR; Carregaro, RL; Cho, J; Cui, Q; Dela Bela, LF; Dias, JM; Dutta, NK; Flowers, ME; Gallo, S; Hari, P; He, R; He, Y; Heimfeld, S; Jia, B; Jin, X; Jin, YJ; Karakousis, PC; Karmakar, T; Kiem, HP; Kreager, DA; Lebedev, D; Li, F; Li, S; Liang, N; Liu, Z; Luo, J; Luo, Y; Mazuquin, BF; Meng, Y; Mosialos, G; Moura, FA; Müller, CR; Naeem, MA; Nagappa, LK; Nguyen, H; Pelegrinelli, AR; Pinn, ML; Prahlada Rao, VS; Pulsipher, MA; Ragan, DT; Richards, J; Roy, S; Sandmaier, BM; Selfe, J; Selim, MA; Shi, J; Shi, X; Staff, J; Storb, R; Storer, BE; Wang, F; Wang, M; Wang, S; Woolfrey, AE; Wright, T; Ylostalo, JH; Zhang, JY; Zhang, ZY; Zheng, K; Zhu, Z | 1 |
| Dürr, C; Follo, M; Idzko, M; Reichardt, W; Zeiser, R | 1 |
| Au, WY; Fung, A; Kwong, YL; Lam, CC; Lam, KY; Lie, AK | 1 |
7 other study(ies) available for phenylalanine and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Eye amputation following lifitegrast treatment for ocular graft-versus-host disease - Response to Novartis.
Topics: Amputation, Surgical; Graft vs Host Disease; Humans; Phenylalanine; Sulfones | 2021 |
Eye amputation following lifitegrast treatment for ocular graft-versus-host disease - Response from the Xiidra® product owner.
Topics: Amputation, Surgical; Graft vs Host Disease; Humans; Phenylalanine; Sulfones | 2021 |
Lifitegrast ophthalmic solution for treatment of ocular chronic graft-versus-host disease.
Topics: Chronic Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Keratoconjunctivitis Sicca; Phenylalanine; Prospective Studies; Retrospective Studies; Sulfones | 2020 |
Eye amputation following lifitegrast treatment for ocular graft-versus-host disease: First case report.
Topics: Aged; Amputation, Surgical; Dry Eye Syndromes; Graft vs Host Disease; Humans; Phenylalanine; Sulfones | 2021 |
Topics: Adolescent; Adult; Age Factors; Aged; Amino Acid Substitution; Anemia, Aplastic; Athletes; Athletic Performance; Bone Marrow Transplantation; Carcinoma, Non-Small-Cell Lung; Catalytic Domain; Cell Count; Child; Child, Preschool; Escherichia coli; Female; Gene Expression; Graft Survival; Graft vs Host Disease; Histocompatibility Testing; Humans; Hydrogen Bonding; Immunosuppression Therapy; Inosine Monophosphate; Integrin alphaVbeta3; Kinetics; Knee Joint; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Molecular Dynamics Simulation; Muscle, Skeletal; Mutation; Organotechnetium Compounds; Pentosyltransferases; Peptides, Cyclic; Phenylalanine; Plasmodium falciparum; Protein Interaction Domains and Motifs; Protein Structure, Secondary; Protozoan Proteins; Radiopharmaceuticals; Recombinant Proteins; Running; Sensitivity and Specificity; Serine; Siblings; Single Photon Emission Computed Tomography Computed Tomography; Soccer; Structure-Activity Relationship; Substrate Specificity; Thermodynamics; Threonine; Time Factors; Torque; Treatment Outcome; Tryptophan; Tyrosine; Young Adult | 2016 |
Graft-versus-host disease reduces regulatory T-cell migration into the tumour tissue.
Topics: Animals; Cell Movement; Cells, Cultured; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Inflammation; Intestines; Lymphoma, B-Cell; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Naphthalenes; Phenylalanine; Receptors, CCR3; Receptors, Purinergic P2Y2; Signal Transduction; T-Lymphocytes, Regulatory; Transplantation, Homologous; Tumor Microenvironment | 2012 |
Reemergence of JAK2 V617F clone heralds extramedullary leukemia relapse after BMT for transformed essential thrombocytosis.
Topics: Bone Marrow Transplantation; Graft vs Host Disease; Humans; Janus Kinase 2; Leukemia; Male; Middle Aged; Mutation; Phenylalanine; Recurrence; Thrombocythemia, Essential; Treatment Failure; Valine | 2007 |